Ucrainenii de la Biopharma își dublează investiția în fabrica de medicamente de la Oradea: 85 de milioane de euro / Producție de peste un milion de litri de plasmă pe an

Ukrainian pharmaceutical company Biopharma is doubling its investment in Oradea, with the first phase costing 85 million euros. This amount exceeds the initial minimum announced in 2024. The project will be completed in four phases, with the first phase focused on production line setup. The factory will process up to 1.2 million liters of frozen human plasma annually. Biopharma, established in 1965, is one of the largest plasma fractionation operators in Eastern Europe.